Review article: gastro-oesophageal reflux disease--pathophysiological issues of clinical relevance (Q34669257)

3 August 2017

1 reference

title

Review article: gastro-oesophageal reflux disease--pathophysiological issues of clinical relevance (English)

1 reference

3 August 2017

1 reference

Penagini R

1

1 reference

3 August 2017

Carmagnola S

series ordinal

2

1 reference

3 August 2017

Cantu P

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

1 reference

3 August 2017

16 Suppl 4

1 reference

3 August 2017

65-71

1 reference

Costs of acid-related disorders to a health maintenance organization

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

21 January 2018

Heartburn--the acid test

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Transient lower esophageal sphincter relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Gastric emptying: a contributory factor in gastro-oesophageal reflux activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Mechanisms of gastroesophageal reflux in ambulant healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

The effect of hiatus hernia on gastro-oesophageal junction pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

A higher plant extracellular vitronectin-like adhesion protein is related to the translational elongation factor-1 alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Impairment of esophageal emptying with hiatal hernia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Fat and esophageal sensitivity to acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Duodenal fat intensifies the perception of heartburn

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Multivariate analysis of pathophysiological factors in reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

The significance of cagA(+) Helicobacter pylori in reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Opposing time trends of peptic ulcer and reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Composition of gastro-oesophageal refluxate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Declined human esophageal mucin secretion in patients with severe reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Visceral hypersensitivity: facts, speculations, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.10.X

10.1046/J.1365-2036.16.S4.10.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference